Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 10/20 | 0.36 |
| ▸ | ALOX5AP | P20292 | 3/20 | 0.35 |
| ▸ | FEN1 | P39748 | 3/20 | 0.35 |
| ▸ | CNR1 | P21554 | 3/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11939353 | 1.00 | CNR2 (0.36) | CNR2ALOX5APFEN1CNR1SCN9A | |
| SCHEMBL12223906 | 0.97 | CNR2 (0.34) | CNR2ALOX5APFEN1CNR1SCN9A | |
| SCHEMBL10302857 | 0.96 | CNR2 (0.38) | CNR2ALOX5APFEN1CNR1SCN9A | |
| SCHEMBL12223491 | 0.96 | CNR2 (0.38) | CNR2ALOX5APFEN1CNR1SCN9A | |
| SCHEMBL11939931 | 0.94 | CNR2 (0.34) | CNR2ALOX5APFEN1CNR1 | |
| SCHEMBL11939170 | 0.94 | CNR2 (0.34) | CNR2ALOX5APFEN1CNR1 | |
| SCHEMBL11939128 | 0.94 | FPR2 (0.34) | ALOX5APFEN1 | |
| SCHEMBL12223321 | 0.93 | GPR119 (0.34) | CNR2ALOX5APFEN1CNR1SCN9A | |
| SCHEMBL12223510 | 0.93 | GPR119 (0.34) | CNR2ALOX5APFEN1CNR1SCN9A | |
| SCHEMBL10091383 | 0.93 | CNR2 (0.36) | CNR2ALOX5APFEN1CNR1SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120168677-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120168677-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CXCR1, OCIAD1, LEO1 | CNR2 474/4885ALOX5AP 903/4885FEN1 1475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.